biotech

The cluster management organizations BioM, based in Munich, Germany, and Osaka Bio Headquarters, based in Osaka, Japan, officially announced the renewal of their long-standing Transnational Biotech & Life Sciences Cooperation Partnership Agreement on the occasion of the EU-Japan Biotech & Pharma Partnering Conference 2022 in Osaka.

TreeFrog Therapeutics (https://treefrog.fr/) is a French biotechnology company specialized in cell therapy. In April 2022, Treefrog announced the opening of a lab in Kobe, Japan, with the aim of establishing strategic alliances with key academic and industrial players in the field of regenerative medicine. Discover the company’s reception in Japan, their encountered challenges, and recommendations to other EU SMEs by reading our Case Study.

Representatives from 10 EU Biotech companies from 7 EU member states travelled to Osaka and Yokohama to meet Japanese life sciences and pharma companies.

Japan spends consistently over 3% of its GDP on R&D, of which some 70% come from industry. Concerning biotech-related R&D, more than half is directed towards pharmaceutical and medical goals, but agricultural, industrial and environmental biotech are recently getting more attention in view of a future “bioeconomy” based on “smart cells” and a better integration of biological and digital innovations.

To get the access to this report, please click here.

To get the access to this report, please click here.